Literature DB >> 33518185

Fertility Issues in Polycystic Ovarian Disease: A Systematic Approach.

John S Rushing1, Nanette Santoro2.   

Abstract

The triad of hirsutism, amenorrhea, and enlarged polycystic ovaries first was described in 1935 and later become known as polycystic ovarian syndrome (PCOS). Women with PCOS are more likely to have cardiometabolic challenges that also have an indirect relationship to their fertility and fertility outcomes. Despite these challenges, their fertile life span appears to be longer. Ovulation induction is considered first-line management of infertility in women with PCOS, with letrozole superior to clomiphene. Women with PCOS undergoing in vitro fertilization are high risk for ovarian hyperstimulation syndrome but also have a higher live birth rate compared with controls.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fertility; IVF; OHSS; Ovulation induction; PCOS

Year:  2021        PMID: 33518185     DOI: 10.1016/j.ecl.2020.10.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

1.  Efficacy and Safety of Cangfu Daotan Decoction in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Linling Wu; Han Zhang; Mengxiao Fan; Ying Yan
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-17       Impact factor: 2.650

2.  The Effect of Age on IVF-ET Outcome in Infertile Patients with PCOS Based on Tiangui Theory in Chinese Medicine.

Authors:  Hui Chang; Jian Li; Qi Wu; Xin Fu; Mengyi Zhu; Hang Ge; Baichao Shi; Xiaoguang Shao; Yanhua Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-22       Impact factor: 2.650

Review 3.  Effect of TSH on oocyte maturation of PCOS patients with normal thyroid function in IVF.

Authors:  Shaoyuan Xu; Cancan Qiang; Ying Zhang; Changjun Zhang
Journal:  Reprod Biol Endocrinol       Date:  2022-09-02       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.